Posted on by Dr.S.Harsha Vardhan

Osimertinib Improves Overall Survival in EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status

Share The Content :

(Refresh the page or download this document incase the PDF doesn’t load properly)

Download This Document

Source : Journal of Thoracic Oncology


Share The Content :

Leave a Reply